×
Pro Analysis

Top trader Najarian, up 10% YTD, buys biotech

Jon Najarian, Najarian Family Office
Adam Jeffery | CNBC
Jon Najarian, Najarian Family Office

CNBC "Halftime Report" trader Jon Najarian bought shares of AbbVie for his model portfolio in CNBC Pro's trading competition. Najarian's portfolio is up 10 percent year-to-date.

In other moves, Najarian sold Synchrony Financial and First Solar.

Read below to find out why Najarian is bullish on the biotech company.